Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Webster

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 2, 2004
Characterization of cigarette smoke-induced inflammatory and mucus hypersecretory changes in rat lung and the role of CXCR2 ligands in mediating this effectChristopher S Stevenson, Kevin Coote, Ruth Webster, et al.
Neuroimage|January 8, 2017
Opioid suppression of conditioned anticipatory brain responses to breathlessnessAnja Hayen, Vishvarani Wanigasekera, Olivia K Faull, et al.
Journal of Hypertension|March 4, 2016
Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetesYoichiro Hirakawa, Hisatomi Arima, Ruth Webster, et al.
American Heart Journal|October 5, 2020
Ultra-low-dose quadruple combination blood pressure-lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocolClara K Chow, Emily R Atkins, Laurent Billot, et al.
JAMA Cardiology|July 28, 2020
Association of Low-Dose Triple Combination Therapy With Therapeutic Inertia and Prescribing Patterns in Patients With Hypertension: A Secondary Analysis of the TRIUMPH TrialNelson Wang, Abdul Salam, Ruth Webster, et al.
Plos One|June 8, 2011
An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk, Anthony Rodgers, Anushka Patel, et al.
International Journal for Equity in Health|June 25, 2017
Healthcare expenditure on Indigenous and non-Indigenous Australians at high risk of cardiovascular diseaseBlake Angell, Tracey-Lea Laba, Tom Lung, et al.
The Medical Journal of Australia|December 16, 2014
An economic case for a cardiovascular polypill? A cost analysis of the Kanyini GAP trialTracey-Lea Laba, Alison Hayes, Serigne Lo, et al.
BMJ Open|June 27, 2025
Process evaluation of a randomised trial of a triple low-dose combination pill strategy to improve hypertension control: a qualitative studyAbdul Salam, Tracey Laba, Rupasvi Dhurjati, et al.
Implementation Science : IS|September 25, 2016
An integrated general practice and pharmacy-based intervention to promote the use of appropriate preventive medications among individuals at high cardiovascular disease risk: protocol for a cluster randomized controlled trialAdina Hayek, Rohina Joshi, Tim Usherwood, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 2, 2004
Characterization of cigarette smoke-induced inflammatory and mucus hypersecretory changes in rat lung and the role of CXCR2 ligands in mediating this effectChristopher S Stevenson, Kevin Coote, Ruth Webster, et al.
Neuroimage|January 8, 2017
Opioid suppression of conditioned anticipatory brain responses to breathlessnessAnja Hayen, Vishvarani Wanigasekera, Olivia K Faull, et al.
Journal of Hypertension|March 4, 2016
Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetesYoichiro Hirakawa, Hisatomi Arima, Ruth Webster, et al.
American Heart Journal|October 5, 2020
Ultra-low-dose quadruple combination blood pressure-lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocolClara K Chow, Emily R Atkins, Laurent Billot, et al.
JAMA Cardiology|July 28, 2020
Association of Low-Dose Triple Combination Therapy With Therapeutic Inertia and Prescribing Patterns in Patients With Hypertension: A Secondary Analysis of the TRIUMPH TrialNelson Wang, Abdul Salam, Ruth Webster, et al.
Plos One|June 8, 2011
An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk, Anthony Rodgers, Anushka Patel, et al.
International Journal for Equity in Health|June 25, 2017
Healthcare expenditure on Indigenous and non-Indigenous Australians at high risk of cardiovascular diseaseBlake Angell, Tracey-Lea Laba, Tom Lung, et al.
The Medical Journal of Australia|December 16, 2014
An economic case for a cardiovascular polypill? A cost analysis of the Kanyini GAP trialTracey-Lea Laba, Alison Hayes, Serigne Lo, et al.
BMJ Open|June 27, 2025
Process evaluation of a randomised trial of a triple low-dose combination pill strategy to improve hypertension control: a qualitative studyAbdul Salam, Tracey Laba, Rupasvi Dhurjati, et al.
Implementation Science : IS|September 25, 2016
An integrated general practice and pharmacy-based intervention to promote the use of appropriate preventive medications among individuals at high cardiovascular disease risk: protocol for a cluster randomized controlled trialAdina Hayek, Rohina Joshi, Tim Usherwood, et al.
Pageof 9